SCHEMBL18797975

SCHEMBL18797975

CC(=O)CCC(=O)N[C@H]1Cc2cccc(C(O)OCOC(=O)OC3CCOCC3)c2OB1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21539650 0.86 MTNR1A (0.35) —
SCHEMBL18797966 0.86 MTNR1A (0.35) —
SCHEMBL17337159 0.85 KAT2B (0.32) —
SCHEMBL17337156 0.85 KAT2B (0.32) —
SCHEMBL23129981 0.85 — —
SCHEMBL19228023 0.83 ALDH1A1 (0.30) —
SCHEMBL18797968 0.83 KMT2A (0.31) —
SCHEMBL19662835 0.83 MTNR1A (0.31) —
SCHEMBL18797962 0.82 PRMT5 (0.32) —
SCHEMBL18797977 0.80 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9637504-B2 Beta-lactamase inhibitors VenatoRx Pharmaceuticals, Inc. (US) 2017-05-02 — — US disclosed
Send feedback